Malaysia Eyes Up to $12 Billion Herbal Market by 2036 With Halal Edge

A Ten-Year Play on Medicinal Plants

Malaysia is positioning itself to capture between RM30 billion and RM50 billion in economic value from its herbal industry by 2036, according to Health Minister Dzulkefly Ahmad. The government convened the inaugural National Herbal Development Council meeting to map out policy priorities and coordinate public and private investment toward making the country a regional bioherbal innovation center.

The target rests on several pillars: commercial cultivation of high-priority medicinal plants, clinical validation of herbal therapies, and artificial-intelligence-driven phytochemical discovery. Dzulkefly outlined the strategy after chairing the council session, emphasizing that genomic and metabolomic research, intellectual property protection, and international patent filings will underpin the push. Export-focused halal herbal products form a core revenue stream, tapping into the expanding Muslim healthcare market.

Biodiversity Meets Biotechnology

Malaysia ranks twelfth on the National Biodiversity Index and sits among seventeen megadiverse nations. Peninsular Malaysia alone counts roughly 1,200 plant species with documented medicinal properties, giving domestic researchers and manufacturers a broad palette of raw material. The government intends to pair that natural endowment with precision medicine techniques and biotechnology platforms housed at institutions such as the Institute for Medical Research and the Forest Research Institute Malaysia.

The plan also leans on the Malaysian Herbal Monograph, a compendium that catalogs traditional uses and scientific evidence for local botanicals. By integrating advanced genomic tools with traditional knowledge, policymakers hope to accelerate the identification of bioactive compounds and shorten the path from laboratory bench to commercial formulation. Strengthening regulatory pathways to meet international standards is part of the same agenda, designed to ease market access in Europe, the Middle East, and North America.

Halal Certification as a Market Key

Malaysia's halal certification system, recognized across more than one hundred countries, offers a structural advantage. The framework covers not only food but also pharmaceuticals and cosmetics, allowing herbal product makers to tap demand in Indonesia, the Gulf states, and parts of Africa where halal compliance is a purchasing prerequisite. The government sees this as a differentiator against competitors in Thailand, India, and China, which produce herbal goods at scale but lack the same halal infrastructure.

The council meeting brought together representatives from SME Corp, the Malaysian Research Accelerator for Technology and Innovation, the Ministry of Agriculture and Food Security, and the Ministry of Natural Resources and Environmental Sustainability. The whole-of-government approach is intended to align land-use policy, research funding, export promotion, and quality standardization under a single strategic umbrella. Private industry players and universities are expected to contribute research capacity and commercialization expertise.

Building the Supply Chain

Realizing the RM30 billion to RM50 billion ambition will require scaling up cultivation areas for priority species, many of which currently grow wild or in smallholder plots. The government is exploring contract-farming models and cooperative structures to secure stable supply while maintaining quality control. Downstream, manufacturers will need to invest in extraction, formulation, and packaging facilities that meet Good Manufacturing Practice standards and can handle export volumes.

Intellectual property protection remains a sticking point. Malaysia has historically struggled to secure patents on traditional herbal formulations, with much of the prior art residing in oral traditions or unpublished texts. The council's emphasis on international patents signals an intent to formalize that knowledge, though navigating prior-art disputes and benefit-sharing arrangements with indigenous communities will take careful legal work.

Regional Context

The bioherbal push unfolds as Southeast Asian governments compete to capture value from traditional medicine. Thailand has built a thriving spa and wellness sector around herbal products, while Indonesia is expanding cultivation of jamu ingredients for domestic and export markets. Singapore positions itself as a regulatory and intellectual-property hub, hosting clinical trials and patent filings for regional companies. Malaysia's strategy threads between these models, combining upstream biodiversity assets with midstream research infrastructure and downstream halal branding.

If execution matches ambition, the next decade will see Malaysia shift from exporting raw botanical material to finished, certified herbal pharmaceuticals and nutraceuticals. Whether the RM50 billion ceiling proves realistic depends on coordination across ministries, sustained research funding, and the ability of local firms to compete on quality and scale in a crowded regional market.